The American Cancer Society estimates that more than 220,000 men will be diagnosed with prostate cancer in 2015. Around 1 in 7 men will be diagnosed during their lifetimes. This September, the RadNet Prostate MRI program encourages men to learn more about prostate cancer and their prostate cancer imaging options.
In order to raise awareness of Prostate Cancer Month, Dr. Princenthal recently visited KCAL-9 to talk about some of the issues involved in the prevention and treatment of prostate cancer. It’s the second most common cancer among men, with over 220,000 new cases every year, yet many men aren’t aware of how to protect themselves with basic screening techniques, like the PSA blood test or prostate MRI.
Multiparametric MRI is one of the latest and most effective tools employed to detect prostate cancer. It supplements ordinary MRI scans with additional imaging in order to provide radiologists with detailed anatomical information about the patient’s prostate gland. If a tumor is detected, multiparametric MRI allows radiologists to measure its size, map its position, determine its stage, estimate its Gleason score, and check whether it has spread beyond the prostate.
